Problem statement: Answer the multiple-choice question.
Question: Which drug has a 14.466% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a. CC1CC(C)CN(C(=O)CCNC(=O)Cn2cnc3ccccc3c2=O)C1
b. CCC(C)n1c(O)c(C=NCCc2ccccc2)c(=O)[nH]c1=S
c. Cc1cccc(Oc2ncnc3onc(C)c23)c1
Answer: b. CCC(C)n1c(O)c(C=NCCc2ccccc2)c(=O)[nH]c1=S
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(C)n1c(O)c(C=NCCc2ccccc2)c(=O)[nH]c1=S
CCC(C)n1c(O)c(C=NCCc2ccccc2)c(=O)[nH]c1=S
1-butan-2-yl-6-hydroxy-5-(2-phenylethyliminomethyl)-2-sulfanylidenepyrimidin-4-one